Synthetic cannabinoids (SCBs) are recreational drugs that are readily available and marketed under various disingenuous brand names. They have gained increasing popularity among young adults, including military soldiers. Initially designed to study effects on pain and brain functioning, these drugs have evolved rapidly and are often used for their lasting euphoric effects. Their relatively cheap cost, easy availability and lack of detection in commercial urine drugs screening tests, has led to an increase in use of SCBs. Due to their unpredictable toxicity and abuse potential, they continue to pose a large public health concern. Treatment, even though not clearly defined, often involves supportive care and symptoms management. Additional studies are required to better understand the various risks and adverse health outcomes that SCBs pose to the general public.
Sarah M Dhannoon, Ali A Alsaad and Sayed K Ali